We find that MIR200CHG and YB-1 bind stably in breast cancer cells, and the changes in the expression of MIR200CHG do not affect the level of YB-1 mRNA but affect the post translational modification status of YB-1. The gene discussed is YBX1; the disease is breast carcinoma.